Ticker Details
Recursion Pharmaceuticals, Inc.
IPO Date:	April 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 3.83%
Avg Daily Range (30 D):	$0.09 | 2.72%
Avg Daily Range (90 D):	$0.11 | 2.95%

Institutional Daily Volume
Avg Daily Volume:	8.77M
Avg Daily Volume (30 D):	11.82M
Avg Daily Volume (90 D):	15.06M

Trade Size
Avg Trade Size (Sh.):	244
Avg Trade Size (Sh.) (30 D):	255
Avg Trade Size (Sh.) (90 D):	299

Institutional Trades
Total Institutional Trades:	2,867
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$1.82M
Avg Institutional Trade (90 D):	$1.99M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.91M
Avg Closing Trade (30 D):	$3.01M
Avg Closing Trade (90 D):	$3.46M
Avg Closing Volume:	554.42K

News

May 25, 2026 @ 11:30 PM Recursion Pharmaceuticals Just Hit a 52-Week Low. ... Source: Prosper Junior Bakiny

May 13, 2026 @ 5:00 PM Global AI in Life Sciences Market Gearing Up for O... Source: Delveinsight

May 8, 2026 @ 11:30 AM 3 Stocks Poised to Disrupt the Healthcare Market b... Source: Jeff Siegel

Mar 31, 2026 @ 1:00 PM Recursion Expands Strategic Partnership with Citel... Source: Na

Mar 22, 2026 @ 5:27 PM Prediction: The "Trough of Disillusionment" Will C... Source: James Brumley

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.22	$-.17	$-1.44
Diluted EPS	$-.22	$-.17	$-1.44
Revenue	$6.47M	$35.54M	$74.68M
Gross Profit	$-6.02M	$21.26M	$3.73M
Net Income / Loss	$-117.5M	$-108.12M	$-644.76M
Operating Income / Loss	$-128.51M	$-108.33M	$-648.13M
Cost of Revenue	$12.49M	$14.28M	$70.95M
Net Cash Flow	$-88.74M	$86.78M	$150.9M
PE Ratio